Search Results - "Suttorp, N"

Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors by von Baum, H, Welte, T, Marre, R, Suttorp, N, Ewig, S, CAPNETZ study group

“…The aim of the present study was to determine the relevance of the presence of Enterobacteriaceae (EB) and Pseudomonas aeruginosa (PA) in patients with…”
Get full text

Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes by Kruger, S, Ewig, S, Marre, R, Papassotiriou, J, Richter, K, von Baum, H, Suttorp, N, Welte, T, on behalf of CAPNETZ Study Group

“…The aim of the present study was to investigate the prognostic value, in patients with community-acquired pneumonia (CAP), of procalcitonin (PCT) compared with…”
Get full text

Assessment of oxygenation and comorbidities improves outcome prediction in patients with community‐acquired pneumonia with a low CRB‐65 score by Kolditz, M., Ewig, S., Schütte, H., Suttorp, N., Welte, T., Rohde, G.

“…Background Addition of assessment of comorbid diseases (‘D’) and oxygen saturation (‘S’) to the CRB‐65 score has been recommended to improve its accuracy for…”
Get full text

CRB‐65 predicts death from community‐acquired pneumonia by BAUER, T. T., EWIG, S., MARRE, R., SUTTORP, N., WELTE, T.

“… Objective.  The study was performed to validate the CURB, CRB and CRB‐65 scores for the prediction of death from community‐acquired pneumonia (CAP) in both…”
Get full text

Outcome of community-acquired pneumonia: influence of age, residence status and antimicrobial treatment by Kothe, H, Bauer, T, Marre, R, Suttorp, N, Welte, T, Dalhoff, K, Competence Network for Community-Acquired Pneumonia study group

“…Community-acquired pneumonia remains a major cause of mortality in developed countries. There is much discrepancy in the literature regarding factors…”
Get full text

The revised dengue fever classification in German travelers: clinical manifestations and indicators for severe disease by Hoffmeister, B., Suttorp, N., Zoller, T.

“…Background The number of dengue cases imported to Germany has increased significantly in recent years. Among returning travelers, dengue is now a frequent…”
Get full text

Impact of intravenous β-lactam/macrolide versus β-lactam monotherapy on mortality in hospitalized patients with community-acquired pneumonia by Tessmer, A., Welte, T., Martus, P., Schnoor, M., Marre, R., Suttorp, N.

“…Objectives Guidelines recommend dual-therapy consisting of a β-lactam/macrolide (BLM) for hospitalized patients with community-acquired pneumonia…”
Get full text

The burden of pneumococcal pneumonia - experience of the German competence network CAPNETZ by Pletz, M W, von Baum, H, van der Linden, M, Rohde, G, Schütte, H, Suttorp, N, Welte, T

“…Pneumococcal pneumonia is still an important cause of mortality. The objective of this study was to compare frequency, clinical presentation, outcome and…”
Get more information

Suppression of pulmonary innate host defence in smokers by Herr, C, Beisswenger, C, Hess, C, Kandler, K, Suttorp, N, Welte, T, Schroeder, J-M, Vogelmeier, C

“…Smoking increases the susceptibility to pulmonary infection and is a risk factor for the development of chronic obstructive pulmonary disease (COPD). It is…”
Get more information

Influenza vaccination is associated with reduced severity of community-acquired pneumonia by TESSMER, A, WELTE, T, SCHMIDT-OTT, R, EBERLE, S, BARTEN, G, SUTTORP, N, SCHABERG, T

“…Pneumonia is an important cause of influenza-associated morbidity and mortality. Influenza vaccination has been shown to reduce morbidity and mortality during…”
Get full text

Spleen tyrosine kinase inhibition blocks airway constriction and protects from Th2‐induced airway inflammation and remodeling by Tabeling, C., Herbert, J., Hocke, A. C., Lamb, D. J., Wollin, S. L., Erb, K. J., Boiarina, E., Movassagh, H., Scheffel, J., Doehn, J. M., Hippenstiel, S., Maurer, M., Gounni, A. S., Kuebler, W. M., Suttorp, N., Witzenrath, M.

“…Background Spleen tyrosine kinase (Syk) is an intracellular nonreceptor tyrosine kinase, which has been implicated as central immune modulator promoting…”
Get full text

Localablative treatment for synchronous oligometastatic lung cancer: A propensity score analysis of 180 patients by Frost, N., Tessmer, A., Schmittel, A., van Laak, V., Ochsenreither, S., Temmesfeld-Wollbrück, B., Schmidt, B., Suttorp, N., Witzenrath, M., Grohe, C.

Get full text

How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired Pneumonia by von Baum, H, Schweiger, B, Welte, T, Marre, R, Suttorp, N, Pletz, M W R, Ewig, S

“…The emergence of new influenza virus subtypes has rekindled the interest in the clinical course and outcome of patients with influenza-associated pneumonia…”
Get full text

Lung perfusion and emphysema distribution affect the outcome of endobronchial valve therapy by Thomsen, Christian, Theilig, Dorothea, Herzog, Dominik, Poellinger, Alexander, Doellinger, Felix, Schreiter, Nils, Schreiter, Vera, Schürmann, Dirk, Temmesfeld-Wollbrueck, Bettina, Hippenstiel, Stefan, Suttorp, Norbert, Hubner, Ralf-Harto

“…The exclusion of collateral ventilation (CV) and other factors affect the clinical success of endoscopic lung volume reduction (ELVR). However, despite its…”
Get full text

Moxifloxacin is not anti-inflammatory in experimental pneumococcal pneumonia by Müller-Redetzky, H C, Wienhold, S M, Berg, J, Hocke, A C, Hippenstiel, S, Hellwig, K, Gutbier, B, Opitz, B, Neudecker, J, Rückert, J, Gruber, A D, Kershaw, O, Mayer, K, Suttorp, N, Witzenrath, M

“…Anti-inflammatory functions of antibiotics may counteract deleterious hyperinflammation in pneumonia. Moxifloxacin reportedly exhibits immunomodulatory…”
Get full text

New Pathogenetic Concepts and Pharmacological Studies on Adjuvant Therapy in Severe Pneumonia by Lienau, J, Müller-Redetzky, H, Suttorp, N, Witzenrath, M

“…Acute lung injury secondary to pneumonia results from inadequate activation of the innate immune system with hyperinflammation and alveolar-capillary barrier…”
Get more information

Moxifloxacin monotherapy versus ß-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia by Ewig, S, Hecker, H, Suttorp, N, Marre, R, Welte, T

“…Summary Objective In this observational study, we compared the outcomes of moxifloxacin monotherapy as compared to ß-lactam monotherapy as well as ß-lactam…”
Get full text

CAPNETZ-community-acquired pneumonia competence network by Welte, T, Suttorp, N, Marre, R

Get full text

Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study by Lepper, Philipp M, Ott, Sebastian, Nüesch, Eveline, von Eynatten, Maximilian, Schumann, Christian, Pletz, Mathias W, Mealing, Nicole M, Welte, Tobias, Bauer, Torsten T, Suttorp, Norbert, Jüni, Peter, Bals, Robert, Rohde, Gernot

“…Objective To examine whether acute dysglycaemia predicts death in people admitted to hospital with community acquired pneumonia.Design Multicentre prospective…”
Get full text

Moxifloxacin monotherapy versus β-lactam mono- or combination therapy in hospitalized patients with community-acquired pneumonia by EWIG, S, HECKER, H, SUTTORP, N, MARRE, R, WELTE, T

Get full text